Agilent Technologies, Inc. $A Holdings Trimmed by Savant Capital LLC

Savant Capital LLC lowered its position in shares of Agilent Technologies, Inc. (NYSE:A) by 87.9% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,603 shares of the medical research company’s stock after selling 26,122 shares during the quarter. Savant Capital LLC’s holdings in Agilent Technologies were worth $490,000 at the end of the most recent quarter.

Several other large investors have also bought and sold shares of A. Massachusetts Financial Services Co. MA boosted its stake in Agilent Technologies by 13.8% during the fourth quarter. Massachusetts Financial Services Co. MA now owns 14,147,601 shares of the medical research company’s stock valued at $1,925,064,000 after buying an additional 1,713,216 shares in the last quarter. AQR Capital Management LLC boosted its position in shares of Agilent Technologies by 424.1% in the 2nd quarter. AQR Capital Management LLC now owns 2,041,826 shares of the medical research company’s stock valued at $240,956,000 after purchasing an additional 1,652,244 shares during the period. Ameriprise Financial Inc. boosted its position in shares of Agilent Technologies by 132.2% in the 2nd quarter. Ameriprise Financial Inc. now owns 2,354,111 shares of the medical research company’s stock valued at $277,807,000 after purchasing an additional 1,340,161 shares during the period. SG Americas Securities LLC boosted its position in shares of Agilent Technologies by 3,091.1% in the 4th quarter. SG Americas Securities LLC now owns 808,215 shares of the medical research company’s stock valued at $109,974,000 after purchasing an additional 782,888 shares during the period. Finally, Lazard Asset Management LLC boosted its position in shares of Agilent Technologies by 639.4% in the 2nd quarter. Lazard Asset Management LLC now owns 678,718 shares of the medical research company’s stock valued at $80,093,000 after purchasing an additional 586,931 shares during the period.

Analysts Set New Price Targets

A number of research firms recently weighed in on A. TD Cowen increased their price target on Agilent Technologies from $147.00 to $155.00 and gave the company a “buy” rating in a research report on Thursday, May 28th. UBS Group decreased their price target on Agilent Technologies from $180.00 to $165.00 and set a “buy” rating for the company in a research report on Thursday, February 26th. Barclays increased their price target on Agilent Technologies from $140.00 to $145.00 and gave the company an “overweight” rating in a research report on Thursday, May 28th. Wells Fargo & Company decreased their price target on Agilent Technologies from $165.00 to $160.00 and set an “overweight” rating for the company in a research report on Thursday, May 28th. Finally, Royal Bank Of Canada began coverage on Agilent Technologies in a research report on Wednesday, May 27th. They issued an “outperform” rating and a $153.00 price target for the company. One research analyst has rated the stock with a Strong Buy rating, thirteen have issued a Buy rating and two have issued a Hold rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $161.71.

Agilent Technologies Stock Up 0.6%

Shares of Agilent Technologies stock opened at $138.23 on Friday. The stock has a 50-day moving average price of $117.89 and a 200 day moving average price of $128.30. The company has a market cap of $39.04 billion, a P/E ratio of 27.76, a P/E/G ratio of 2.45 and a beta of 1.26. The company has a current ratio of 2.10, a quick ratio of 1.62 and a debt-to-equity ratio of 0.43. Agilent Technologies, Inc. has a 1 year low of $108.35 and a 1 year high of $160.27.

Agilent Technologies (NYSE:A) last announced its quarterly earnings data on Wednesday, May 27th. The medical research company reported $1.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.41 by $0.08. The firm had revenue of $1.84 billion during the quarter, compared to the consensus estimate of $1.80 billion. Agilent Technologies had a return on equity of 24.33% and a net margin of 19.55%.The business’s revenue for the quarter was up 10.0% on a year-over-year basis. During the same period in the prior year, the business earned $1.31 EPS. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, analysts expect that Agilent Technologies, Inc. will post 5.99 EPS for the current fiscal year.

Agilent Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, July 22nd. Investors of record on Tuesday, June 30th will be paid a $0.255 dividend. This represents a $1.02 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend is Tuesday, June 30th. Agilent Technologies’s dividend payout ratio is currently 20.48%.

Agilent Technologies Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.